Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Feb 20:6:19.
doi: 10.1186/1748-717X-6-19.

Sensorineural hearing loss after concurrent chemoradiotherapy in nasopharyngeal cancer patients

Affiliations

Sensorineural hearing loss after concurrent chemoradiotherapy in nasopharyngeal cancer patients

Janjira Petsuksiri et al. Radiat Oncol. .

Abstract

Background: Sensorineural hearing loss (SNHL) is one of the major long term side effects from radiation therapy (RT) in nasopharyngeal cancer (NPC) patients. This study aims to review the incidences of SNHL when treating with different radiation techniques. The additional objective is to determine the relationship of the SNHL with the radiation doses delivered to the inner ear.

Methods: A retrospective cohort study of 134 individual ears from 68 NPC patients, treated with conventional RT and IMRT in combination with chemotherapy from 2004-2008 was performed. Dosimetric data of the cochlea were analyzed. Significant SNHL was defined as >15 dB increase in bone conduction threshold at 4 kHz and PTA (pure tone average of 0.5, 1, 2 kHz). Relative risk (RR) was used to determine the associated factors with the hearing threshold changes at 4 kHz and PTA.

Results: Median audiological follow up time was 14 months. The incidence of high frequency (4 kHz) SNHL was 44% for the whole group (48.75% in the conventional RT, 37% with IMRT). Internal auditory canal mean dose of >50 Gy had shown a trend to increase the risk of high frequency SNHL (RR 2.02 with 95% CI 1.01-4.03, p=0.047).

Conclusion: IMRT and radiation dose limitation to the inner ear appeared to decrease SNHL.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Patients flow diagram.
Figure 2
Figure 2
Inner ear contouring. C: Cochlea, V: Vestibule, IAC: internal auditory canal Inner ear = cochlea(C) + vestibule (V).
Figure 3
Figure 3
Forest plot for relative risk of SNHL at 4 kHz.
Figure 4
Figure 4
Forest plot for relative risk of SNHL at PTA.

Similar articles

Cited by

References

    1. Al-Sarraf M, LeBlanc M, Giri PG, Fu KK, Cooper J, Vuong T, Forastiere AA, Adams G, Sakr WA, Schuller DE. et al.Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol. 1998;16(4):1310–1317. - PubMed
    1. Wee J, Tan EH, Tai BC, Wong HB, Leong SS, Tan T, Chua ET, Yang E, Lee KM, Fong KW. et al.Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety. J Clin Oncol. 2005;23(27):6730–6738. doi: 10.1200/JCO.2005.16.790. - DOI - PubMed
    1. Huncharek M, Kupelnick B. Combined chemoradiation versus radiation therapy alone in locally advanced nasopharyngeal carcinoma: results of a meta-analysis of 1,528 patients from six randomized trials. Am J Clin Oncol. 2002;25(3):219–223. doi: 10.1097/00000421-200206000-00002. - DOI - PubMed
    1. Chen WC, Jackson A, Budnick AS, Pfister DG, Kraus DH, Hunt MA, Stambuk H, Levegrun S, Wolden SL. Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma. Cancer. 2006;106(4):820–829. doi: 10.1002/cncr.21683. - DOI - PubMed
    1. Chan SH, Ng WT, Kam KL, Lee MC, Choi CW, Yau TK, Lee AW, Chow SK. Sensorineural hearing loss after treatment of nasopharyngeal carcinoma: a longitudinal analysis. Int J Radiat Oncol Biol Phys. 2009;73(5):1335–1342. doi: 10.1016/j.ijrobp.2008.07.034. - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources